{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T21:05:23Z","timestamp":1785618323375,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701418"],"award-info":[{"award-number":["81701418"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The etiology between homocysteine and polycystic ovary syndrome (PCOS) is unclear. In humans, the level of homocysteine is mainly affected by two enzymes: methylene tetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR). While the activity of these two enzymes is mainly affected by three missense mutations, namely C677T (MTHFR), A1298C (MTHFR), and A66G (MTRR). This study aims to examine the association between the three missense mutations and PCOS and investigate whether the three missense mutations exerted their effect on PCOS by affecting the homocysteine level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A case-control study was designed, comprising 150 people with PCOS and 300 controls. Logistic regression analysis was used to assess the association between the three missense mutations and PCOS. Linear regression analysis was used to assess the association between the three missense mutations and the homocysteine level. Mediation analysis was used to investigate whether the three missense mutations exerted their effect on PCOS by affecting the homocysteine level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Following adjustments and multiple rounds of testing, <jats:italic>MTHFR<\/jats:italic> A1298C was found to be significantly associated with PCOS in a dose-dependent manner (compared to AA, OR\u2009=\u20092.142 for AC &amp; OR\u2009=\u20093.755 for CC; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). <jats:italic>MTRR<\/jats:italic> A66G was nominally associated with PCOS. Mutations in <jats:italic>MTHFR<\/jats:italic> A1298C and <jats:italic>MTRR<\/jats:italic> A66G were significantly associated with the homocysteine level. Mediation analysis suggested the effect of <jats:italic>MTHFR<\/jats:italic> A1298C on PCOS was mediated by homocysteine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p><jats:italic>MTHFR<\/jats:italic> A1298C and <jats:italic>MTRR<\/jats:italic> A66G were associated with PCOS, and <jats:italic>MTHFR<\/jats:italic> A1298C might affect the risk of PCOS by influencing the homocysteine level.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12958-020-00688-8","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T04:36:01Z","timestamp":1609994161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Association of three missense mutations in the homocysteine-related MTHFR and MTRR gene with risk of polycystic ovary syndrome in Southern Chinese women"],"prefix":"10.1186","volume":"19","author":[{"given":"Wanqin","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanling","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1856-101X","authenticated-orcid":false,"given":"Ying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"issue":"1","key":"688_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"TREA Group","year":"2004","unstructured":"TREA Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137.","journal-title":"Hum Reprod"},{"issue":"2","key":"688_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","volume":"132","author":"R Azziz","year":"2018","unstructured":"Azziz R. Polycystic ovary syndrome. Obstet Gynecol. 2018;132(2):321\u201336.","journal-title":"Obstet Gynecol"},{"issue":"12","key":"688_CR3","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565\u201392.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"688_CR4","first-page":"267","volume":"50","author":"LG Nardo","year":"2008","unstructured":"Nardo LG, Patchava S, Laing I. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications. Panminerva Med. 2008;50(4):267.","journal-title":"Panminerva Med"},{"issue":"4","key":"688_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/09513590903247873","volume":"26","author":"D Glintborg","year":"2009","unstructured":"Glintborg D, Andersen M. An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome. Gynecol Endocrinol. 2009;26(4):281\u201396.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"688_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2174\/138161212799040457","volume":"18","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Christakou C, Marinakis E. Phenotypes and enviromental factors: their influence in PCOS. Curr Pharm Design. 2012;18(3):270.","journal-title":"Curr Pharm Design"},{"issue":"1","key":"688_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1385\/ENDO:30:1:19","volume":"30","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E, Kandarakis H, Legro RS. The role of genes and environment in the etiology of PCOS. Endocrine. 2006;30(1):19\u201326.","journal-title":"Endocrine"},{"issue":"4","key":"688_CR8","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.fertnstert.2016.08.031","volume":"106","author":"AZ Rutkowska","year":"2016","unstructured":"Rutkowska AZ, Diamanti-Kandarakis E. Polycystic ovary syndrome and environmental toxins. Fertil Steril. 2016;106(4):948\u201358.","journal-title":"Fertil Steril"},{"issue":"5","key":"688_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36(5):487\u2013525.","journal-title":"Endocr Rev"},{"issue":"1","key":"688_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.fertnstert.2016.05.011","volume":"106","author":"SS Merkin","year":"2016","unstructured":"Merkin SS, Phy JL, Sites CK, Yang D. Environmental determinants of polycystic ovary syndrome. Fertil Steril. 2016;106(1):16\u201324.","journal-title":"Fertil Steril"},{"issue":"3","key":"688_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nrendo.2016.9","volume":"12","author":"R Azziz","year":"2016","unstructured":"Azziz R. PCOS in 2015: New insights into the genetics of polycystic ovary syndrome. Nat Rev Endocrinol. 2016;12(3):183.","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"688_CR12","doi-asserted-by":"publisher","first-page":"e1007813","DOI":"10.1371\/journal.pgen.1007813","volume":"14","author":"F Day","year":"2018","unstructured":"Day F, Karaderi T, Drong RM, Kraft A, Lin P, Huang N, Broer H, Magi L, Saxena R, et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLos Genet. 2018;14(12):e1007813.","journal-title":"PLos Genet"},{"issue":"10","key":"688_CR13","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.3390\/jcm8101606","volume":"8","author":"M-A Hiam","year":"2019","unstructured":"Hiam M-A, Laven T. The genetics of polycystic ovary syndrome: an overview of candidate gene systematic reviews and genome-wide association studies. J Clin Med. 2019;8(10):1606.","journal-title":"J Clin Med"},{"issue":"2","key":"688_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/humrep\/dev318","volume":"31","author":"KS Ruth","year":"2016","unstructured":"Ruth KS, Beaumont RN, Tyrrell J, Jones SE, Tuke MA, Yaghootkar H, Wood AR, Freathy RM, Weedon MN, Frayling TM, et al. Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health. Hum Reprod. 2016;31(2):473\u201381.","journal-title":"Hum Reprod"},{"issue":"8","key":"688_CR15","doi-asserted-by":"publisher","first-page":"e1005455","DOI":"10.1371\/journal.pgen.1005455","volume":"11","author":"MR Jones","year":"2015","unstructured":"Jones MR, Brower MA, Xu N, Cui J, Mengesha E, Chen YD, Taylor KD, Azziz R, Goodarzi MO. Systems genetics reveals the functional context of PCOS loci and identifies genetic and molecular mechanisms of disease heterogeneity. PLoS Genet. 2015;11(8):e1005455.","journal-title":"PLoS Genet"},{"issue":"6","key":"688_CR16","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.rbmo.2018.12.046","volume":"38","author":"H Chang","year":"2019","unstructured":"Chang H, Xie L, Ge H, Wu Q, Wen Y, Zhang D, Zhang Y, Ma H, Gao J, Wang CC, et al. Effects of hyperhomocysteinaemia and metabolic syndrome on reproduction in women with polycystic ovary syndrome: a secondary analysis. Reprod Biomed Online. 2019;38(6):990\u20138.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"688_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.rbmo.2018.05.008","volume":"37","author":"D Li","year":"2018","unstructured":"Li D, Liu H, Fang Y, Huo J, Wu Q, Wang T, Zhou Y, Wang X, Ma X. Hyperhomocysteinemia in polycystic ovary syndrome: decreased betaine-homocysteine methyltransferase and cystathionine \u03b2-synthase-mediated homocysteine metabolism. Reprod Biomed Online. 2018;37(2):234\u201341.","journal-title":"Reprod Biomed Online"},{"issue":"10","key":"688_CR18","first-page":"17","volume":"66","author":"A Diwaker","year":"2018","unstructured":"Diwaker A, Kishore D. Evaluation of plasma homocysteine levels in patients of PCOS. J Assoc Physicians India. 2018;66(10):17\u201320.","journal-title":"J Assoc Physicians India"},{"issue":"4","key":"688_CR19","doi-asserted-by":"publisher","first-page":"e231943","DOI":"10.1371\/journal.pone.0231943","volume":"15","author":"FZ Fouani","year":"2020","unstructured":"Fouani FZ, Fadaei R, Moradi N, Zandieh Z, Ansaripour S, Yekaninejad MS, Vatannejad A, Mahmoudi M. Circulating levels of Meteorin-like protein in polycystic ovary syndrome: a case-control study. PLOS ONE. 2020;15(4):e231943.","journal-title":"PLOS ONE"},{"issue":"5","key":"688_CR20","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1210\/en.2017-00039","volume":"158","author":"X Qi","year":"2017","unstructured":"Qi X, Zhang B, Zhao Y, Li R, Chang HM, Pang Y, Qiao J. Hyperhomocysteinemia promotes insulin resistance and adipose tissue inflammation in PCOS mice through modulating M2 macrophage polarization via estrogen suppression. Endocrinology. 2017;158(5):1181\u201393.","journal-title":"Endocrinology"},{"key":"688_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.biochi.2020.02.015","volume":"173","author":"F Portillo","year":"2020","unstructured":"Portillo F, V\u00e1zquez J, Pajares MA. Protein-protein interactions involving enzymes of the mammalian methionine and homocysteine metabolism. Biochimie. 2020;173:33\u201347.","journal-title":"Biochimie"},{"issue":"2","key":"688_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ymgme.2010.03.002","volume":"100","author":"T Forges","year":"2010","unstructured":"Forges T, Chery C, Audonnet S, Feillet F, Gueant J. Life-threatening methylenetetrahydrofolate reductase (MTHFR) deficiency with extremely early onset: Characterization of two novel mutations in compound heterozygous patients. Mol Genet Metab. 2010;100(2):143\u20138.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"688_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111.","journal-title":"Nat Genet"},{"issue":"9791","key":"688_CR24","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0140-6736(11)60872-6","volume":"378","author":"MV Holmes","year":"2011","unstructured":"Holmes MV, Newcombe P, Hubacek JA, Sofat R, Ricketts SL, Cooper J, Breteler MM, Bautista LE, Sharma P, Whittaker JC, et al. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. The Lancet. 2011;378(9791):584\u201394.","journal-title":"The Lancet"},{"issue":"4","key":"688_CR25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10545-011-9418-1","volume":"35","author":"D Watkins","year":"2012","unstructured":"Watkins D, Rosenblatt DS. Update and new concepts in vitamin responsive disorders of folate transport and metabolism. J Inherit Metab Dis. 2012;35(4):665\u201370.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"688_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1006\/mgme.1998.2714","volume":"64","author":"I Weisberg","year":"1998","unstructured":"Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998;64(3):169\u201372.","journal-title":"Mol Genet Metab"},{"issue":"45","key":"688_CR27","doi-asserted-by":"publisher","first-page":"13378","DOI":"10.1021\/bi020536s","volume":"41","author":"H Olteanu","year":"2002","unstructured":"Olteanu H, Munson T, Banerjee R. Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase\u2020. Biochemistry-Us. 2002;41(45):13378\u201385.","journal-title":"Biochemistry-Us"},{"issue":"1","key":"688_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"TREA Group","year":"2004","unstructured":"TREA Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","journal-title":"Fertil Steril"},{"key":"688_CR29","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jad.2020.05.093","volume":"273","author":"Y Yuan","year":"2020","unstructured":"Yuan Y, Li J, Jing Z, Yu C, Zhao D, Hao W, Zhou C. The role of mental health and physical activity in the association between sleep quality and quality of life among rural elderly in China: a moderated mediation model. J Affect Disorders. 2020;273:462\u20137.","journal-title":"J Affect Disorders"},{"issue":"6","key":"688_CR30","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/humupd\/dms030","volume":"18","author":"SS Lim","year":"2012","unstructured":"Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618\u201337.","journal-title":"Hum Reprod Update"},{"key":"688_CR31","doi-asserted-by":"publisher","first-page":"144079","DOI":"10.1016\/j.gene.2019.144079","volume":"719","author":"X Zhu","year":"2019","unstructured":"Zhu X, Hong X, Chen L, Xuan Y, Huang K, Wang B. Association of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms with genetic susceptibility to polycystic ovary syndrome: a PRISMA-compliant meta-analysis. Gene. 2019;719:144079.","journal-title":"Gene"},{"key":"688_CR32","first-page":"501","volume":"63","author":"TBD Santos","year":"2019","unstructured":"Santos TBD, Paula HKD, Balarin MAS, Silva-Grecco RL, Lima MFP, Resende EAMR, Gomes MKO, Cintra MTR. Can the genetic polymorphisms of the folate metabolism have an influence in the polycystic ovary syndrome? Arch Endocrinol Metab. 2019;63:501\u20138.","journal-title":"Arch Endocrinol Metab"},{"issue":"2","key":"688_CR33","first-page":"141","volume":"37","author":"M Szafarowska","year":"2016","unstructured":"Szafarowska M, Segiet A, Jerzak MM. Methylenotetrahydrololate reductase A1298C and C677T polymorphisms and adverse pregnancy outcome in women with PCOS. Neuro Endocrinol Lett. 2016;37(2):141.","journal-title":"Neuro Endocrinol Lett"},{"issue":"4","key":"688_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.17772\/gp\/61751","volume":"87","author":"K O\u017cegowska","year":"2016","unstructured":"O\u017cegowska K, Bogacz A, Bartkowiak-Wieczorek J, Seremak-Mrozikiewicz A, Pawelczyk L. Is there an association between the development of metabolic syndrome in PCOS patients and the C677T MTHFR gene polymorphism? Ginekol Pol. 2016;87(4):246.","journal-title":"Ginekol Pol"},{"issue":"4","key":"688_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1357-2725(99)00138-7","volume":"32","author":"JD Finkelstein","year":"2000","unstructured":"Finkelstein JD, Martin JJ. Homocysteine. Int J Biochem Cell Biol. 2000;32(4):385\u20139.","journal-title":"Int J Biochem Cell Biol"},{"key":"688_CR36","doi-asserted-by":"crossref","unstructured":"Kozakova M, Morizzo C, Penno G, Shore AC, Nilsson J, Palombo C. Plasma homocysteine and cardiovascular organ damage in a population with a high prevalence of risk factors. J Clin Endocrinol Metab. 2020;105(8).","DOI":"10.1210\/clinem\/dgaa289"},{"issue":"1","key":"688_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbrc.2018.04.078","volume":"503","author":"K Mondal","year":"2018","unstructured":"Mondal K, Chakraborty P, Kabir SN. Hyperhomocysteinemia and hyperandrogenemia share PCSK9-LDLR pathway to disrupt lipid homeostasis in PCOS. Biochem Biophys Res Commun. 2018;503(1):8\u201313.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"688_CR38","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.jacc.2007.01.014","volume":"49","author":"N Akhtar","year":"2007","unstructured":"Akhtar N. Is homocysteine a risk factor for atherothrombotic cardiovascular disease? J Am Coll Cardiol. 2007;49(12):1370\u20131.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"688_CR39","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s40618-019-01163-x","volume":"43","author":"N Schiuma","year":"2020","unstructured":"Schiuma N, Costantino A, Bartolotti T, Dattilo M, Bini V, Aglietti MC, Renga M, Favilli A, Falorni A, Gerli S. Micronutrients in support to the one carbon cycle for the modulation of blood fasting homocysteine in PCOS women. J Endocrinol Invest. 2020;43(6):779\u201386.","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"688_CR40","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1447-0756.2007.00699.x","volume":"34","author":"N Yilmaz","year":"2008","unstructured":"Yilmaz N, Pektas M, Tonguc E, Kilic S, Gulerman C, Gungor T, Mollamahmutoglu L. The correlation of plasma homocysteine with insulin resistance in polycystic ovary syndrome. J Obstet Gynaecol Res. 2008;34(3):384\u201391.","journal-title":"J Obstet Gynaecol Res"},{"issue":"7","key":"688_CR41","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00059-013-3761-y","volume":"38","author":"Y Wu","year":"2013","unstructured":"Wu Y, Huang Y, Hu Y, Zhong J, He Z, Li W, Yang Y, Xu D, Wu S. Hyperhomocysteinemia is an independent risk factor in young patients with coronary artery disease in southern China. Herz. 2013;38(7):779\u201384.","journal-title":"Herz"},{"issue":"3","key":"688_CR42","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0015-0282(01)01937-9","volume":"76","author":"H Yaral\u0131","year":"2001","unstructured":"Yaral\u0131 H, Y\u0131ld\u0131r\u0131r A, Aybar F, Kabak\u00e7\u0131 G, B\u00fck\u00fclmez O, Akg\u00fcl E, Oto A. Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertili Sterili. 2001;76(3):511\u20136.","journal-title":"Fertili Sterili"},{"issue":"8","key":"688_CR43","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1080\/10408444.2018.1518404","volume":"48","author":"LA Cox","year":"2018","unstructured":"Cox LA. Modernizing the Bradford Hill criteria for assessing causal relationships in observational data. Crit Rev Toxicol. 2018;48(8):682\u2013712.","journal-title":"Crit Rev Toxicol"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-020-00688-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12958-020-00688-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-020-00688-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T04:41:38Z","timestamp":1609994498000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-020-00688-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["688"],"URL":"https:\/\/doi.org\/10.1186\/s12958-020-00688-8","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"22 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Zhujiang Hospital, Southern Medical University and has been performed in accordance with the principles of Declaration of Helsinki. Written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}